(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ATANIS BIOTECH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ATANIS BIOTECH

ST13

US500000079351017

Class

5, 10, 42, 44

Filing

79351017

Registration

7220649

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

03/27/2025

Trademark type

Word

Nice classes

5, 10, 42, 44

Filing date

07/29/2022

Registration date

11/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2023

Last transaction

03/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

CH

Examiner

DAVIS, MARC

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ATANIS Biotech AG

Representatives

Andrew N. Spivak Mosaic Legal Group, PLLC

Technical classification

Nice Classes

Class 5Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical use

Class 10

Clinical diagnosis apparatus for testing for viruses; medical apparatus and instruments for diagnosing allergies

Class 42

Scientific and technological servicesscientificresearchanalysistesting in the field of medicine; scientific and medical research and pharmaceutical development; design and development of medical diagnostic apparatus

Class 44

Medical testing and analysis for diagnostic purposes; medical analysis services provided by medical laboratories for diagnostic and therapeutic treatment purposes; providing information in the field of medicine

Publications

History of USPTO decisions and trademark events.

30 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/21/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/18/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/26/2024

FIMP

FINAL DISPOSITION PROCESSED

02/26/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/05/2023

PUBO

PUBLISHED FOR OPPOSITION

09/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/04/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/16/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/16/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/16/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/01/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

08/01/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/01/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

08/01/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/27/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/26/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/26/2023

RFNT

REFUSAL PROCESSED BY IB

07/22/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/28/2023

RFRR

REFUSAL PROCESSED BY MPU

06/28/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/20/2023

CNRT

NON-FINAL ACTION WRITTEN

05/19/2023

DOCK

ASSIGNED TO EXAMINER

05/17/2023

MAFR

APPLICATION FILING RECEIPT MAILED

10/04/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/29/2022

Continuous trademark protection

Get notified about every new filing that threatens ATANIS BIOTECH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.